Repligen (RGEN) Interest Coverage Ratio Growth (3y) (2014 - 2026)
Powered by 
Analysis
Repligen (RGEN) Interest Coverage Ratio Growth (3y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn | 2.45% |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn | -16.19% |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn | 40.32% |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn | 61.39% |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn | -33.92% |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn | 11.07% |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn | -6.16% |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn | -62.53% |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn | - |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn | -29.39% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -62.53% |
| Mar 31, 2026 | -56.18% |
| Dec 31, 2025 | -73.80% |
| Sep 30, 2025 | -73.12% |
| Jun 30, 2025 | -77.67% |
| Mar 31, 2025 | -81.73% |
| Dec 31, 2024 | -35.97% |
| Sep 30, 2024 | -27.99% |
| Jun 30, 2024 | -60.48% |
| Mar 31, 2024 | -61.64% |
| Dec 31, 2023 | -8.30% |
| Sep 30, 2023 | 18.74% |
| Jun 30, 2023 | 93.22% |
| Mar 31, 2023 | 104.00% |
| Dec 31, 2022 | 349.83% |
| Sep 30, 2022 | 285.81% |
| Jun 30, 2022 | 232.48% |
| Mar 31, 2022 | 216.64% |
| Dec 31, 2021 | 41.23% |
| Sep 30, 2021 | 50.10% |